Clarius Group LLC’s Nautilus Biotechnolgy NAUT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $769K | Buy |
1,060,460
+193,874
| +22% | +$141K | 0.04% | 178 |
|
2025
Q1 | $746K | Buy |
866,586
+230,054
| +36% | +$198K | 0.05% | 184 |
|
2024
Q4 | $1.07M | Hold |
636,532
| – | – | 0.07% | 115 |
|
2024
Q3 | $1.81M | Hold |
636,532
| – | – | 0.13% | 76 |
|
2024
Q2 | $1.49M | Buy |
636,532
+16,661
| +3% | +$39K | 0.11% | 90 |
|
2024
Q1 | $1.82M | Buy |
619,871
+22,102
| +4% | +$65K | 0.13% | 76 |
|
2023
Q4 | $1.79M | Hold |
597,769
| – | – | 0.15% | 79 |
|
2023
Q3 | $1.89M | Sell |
597,769
-203
| -0% | -$641 | 0.18% | 66 |
|
2023
Q2 | $2.31M | Hold |
597,972
| – | – | 0.18% | 67 |
|
2023
Q1 | $1.66M | Buy |
597,972
+10,667
| +2% | +$29.5K | 0.14% | 82 |
|
2022
Q4 | $1.06M | Buy |
587,305
+82,901
| +16% | +$149K | 0.1% | 129 |
|
2022
Q3 | $1.07M | Hold |
504,404
| – | – | 0.11% | 115 |
|
2022
Q2 | $1.36M | Buy |
504,404
+77,480
| +18% | +$208K | 0.14% | 99 |
|
2022
Q1 | $2.21M | Hold |
426,924
| – | – | 0.17% | 69 |
|
2021
Q4 | $2.21M | Buy |
426,924
+408,663
| +2,238% | +$2.12M | 0.17% | 69 |
|
2021
Q3 | $112K | Buy |
+18,261
| New | +$112K | 0.01% | 424 |
|